Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone.
Park J, Kim CO, Oh ES, Lee JI, Kim JK, Ahn SH, Kim DY, Kim SU, Kim BK, Chung YE, Kim SM, Park MS.
Park J, et al. Among authors: kim jk, kim su, kim dy, kim bk, kim sm, kim co.
Clin Pharmacol Drug Dev. 2022 May;11(5):576-584. doi: 10.1002/cpdd.1045. Epub 2022 Mar 7.
Clin Pharmacol Drug Dev. 2022.
PMID: 35255191